BRIEF-Akcea Completes Enrollment In Phase 2B Study Of Akcea-Apo(A)-LRx By: Reuters: Company News February 07, 2018 at 07:08 AM EST * AKCEA COMPLETES ENROLLMENT IN PHASE 2B STUDY OF AKCEA-APO(A)-LRX Source text for Eikon: Further company coverage: Read More >> Related Stocks: Agilent Technologies Akcea Therapeutics Inc